Clinical and Economic Outcomes of Erythropoiesis-Stimulating Agent Hyporesponsiveness in the Post-Bundling Era

RATIONALE & OBJECTIVE: Since the change in erythropoiesis-stimulating agent (ESA) labeling and bundling of dialysis services in the United States, few studies have addressed the clinical importance of ESA hyporesponsiveness and none have considered health care resource use in this population. We...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Kidney Med
Main Authors: Cizman, Borut, Smith, Helen T., Camejo, Rodrigo Refoios, Casillas, Linda, Dhillon, Harjeet, Mu, Fan, Wu, Eric, Xie, Jipan, Zuckerman, Peter, Coyne, Daniel
Formato: Artigo
Idioma:Inglês
Publicado em: Elsevier 2020
Assuntos:
Original Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7568064/
https://ncbi.nlm.nih.gov/pubmed/33089137
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.xkme.2020.06.008
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados